Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Catalent

Generac Holdings

Match Group

PayPal

Signature Bank

SVB Financial Group

Stanley Black & Decker

V.F.

Warner Bros Discovery Inc

Zebra Technologies

It's been a bad year for most S&P 500 investors. But it's been a disaster for those who owned the biggest turkeys.

Do You Own The Year's 12 Biggest Stock Market Turkeys?

If you're willing to buy and hold, these stocks could generate some fantastic returns for you in the years ahead.

Got $5,000? These 2 Growth Stocks Are Trading Near Multi-Year Lows

Etsy

The current market is volatile and leaning negative, but long-term investors can still find screaming buys.

Got $1,000? 2 Incredible Stocks to Buy in a Bear Market

TEMPE, Ariz--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2023 Research Award Program to support clinical and scientific dental research in universities across the globe.

Align Technology to Award Research Programs That Advance Orthodontic and Dental Patient Care

Desktop Metal

Align Technology and Desktop Metal Announce Strategic Collaboration to Make iTero Element™ Flex the Preferred Restorative Intraoral Scanner for Desktop Labs' Customers Serving General Dentists

Wynn Resorts

Investors are looking at these beaten-down companies closely.

2 Nasdaq Stocks Picking Themselves Off the Mat Monday

Align Technology Announces $200 Million Accelerated Stock Repurchase Agreement Under Its $1 Billion Repurchase Program

Invisalign maker Align Technology Inc. ALGN, +3.91% announced Monday that it has entered into a $200 million accelerated stock repurchase (ASR) program with Goldman Sachs & Co. LLC. The medical device company's stock, which fell 1.4% in premarket trading, has plunged 71.3% this year, to make it the S&P 500's SPX, +2.46% worst year-to-date performer, while the S&P 500 has lost 18.2%.

Invisalign maker Align Technology enters $200 million accelerated stock repurchase program

The maker of Invisalign saw declining revenue and disappointing earnings for the third quarter.

Why Align Technology Dropped As Much As 13.7% This Week

Revenue and profits are down, and the market doesn't like it.

Why Align Technology Stock Got Hammered Today

The volatility surrounding inflationary pressure, weaker consumer confidence and the lingering impacts of COVID-19 shutdowns continue to pose challenges for Align Technology (ALGN).

Align Technology (ALGN) Q3 Earnings Lag Estimates, Margins Drop

Teladoc

Teladoc Health is "hitting its stride," one analyst said Thursday as TDOC stock surged on its third-quarter beat. The post Why Pandemic Darlings Teladoc, Align Diverged On Their Third-Quarter Reports appeared first on Investor's Business Daily.

Why Pandemic Darlings Teladoc, Align Diverged On Their Third-Quarter Reports

Steep declines in former favorites show how much confidence market participants have lost.

Are Investors Giving Up on These 2 Nasdaq Growth Stocks?

Align Technology, Inc. (NASDAQ:ALGN ) Q3 2022 Results Conference Call October 26, 2022 4:30 PM ET Company Participants Shirley Stacy - VP of Corporate Communications and IR Joe Hogan - President, CEO and Director John Morici - CFO Conference Call Participants Jason Bednar - Piper Sandler John Block - Stifel Brandon Couillard - Jefferies Jeff Johnson - Baird Elizabeth Anderson - Evercore ISI Erin Wright - MS Nathan Rich - Goldman Sachs Kevin Caliendo - UBS Operator Greetings. Welcome to the Align Q3 2022 Earnings Call.

Align Technology, Inc. (ALGN) Q3 2022 Earnings Call Transcript

Align Technology (ALGN) delivered earnings and revenue surprises of -38.46% and 8.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Align Technology (ALGN) Misses Q3 Earnings and Revenue Estimates

Align Technology Announces Third Quarter 2022 Financial Results

Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Align Technology (ALGN) to Report a Decline in Earnings: What to Look Out for

Carnival

Caesars Entertainment

DISH Network

It's understandable S&P 500 investors try to jump in early. But that dip-buying is only burning investors this year as the bottom falls out.

9 Tempting Stocks Burn Overeager Dip Buyers Every Time

Johnson & Johnson

If you have extra money to invest in the stock market right now, these two mainstays are worth considering.

Have $2,000? 2 Trusty Stocks to Buy Now

If you're a bargain hunter, there's certainly no shortage of discounted stocks right now. Here's what to look for.

Should You Buy the S&P 500's 3 Worst-Performing 2022 Stocks?

Visa

These stocks may be down now, but they're likely to recover in the long run.

2 No-Brainer Buys in This Bear Market

SmileDirectClub

DENTSPLY SIRONA

The orthodontic treatment market has experienced substantial recovery, primarily owing to the easing of restrictions and mass opening up of the economy in 2022.

3 Stocks From the Growing Digital Orthodontic Space in Focus

TEMPE, Ariz. & PALMA DE MALLORCA, Spain--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today introduced the latest release of the iTero-exocad Connector,™ which integrates iTero intraoral camera and NIRI images within exocad DentalCAD 3.1 Rijeka softw

Align Technology Introduces Latest iTero-exocad Connector™ Software Release That Enables Advanced Visualization for Doctors and Labs, With Seamless Integration of iTero™ Intraoral Camera and NIRI Images Within exocad™ Software

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2022 financial results on Wednesday, October 26, 2022, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and

Align Technology to Announce Third Quarter 2022 Results on October 26, 2022

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today introduced Invisalign Virtual Care AI, its next generation remote monitoring solution with new artificial intelligence-assisted capabilities that streamline workflows for doctors and their

News for Align Technology Stock (ALGN)